So, in a very real sense, his bad night in the bar, just keeps costing Merck more and more. Here is the Corporate Crime Reporter story -- and a bit:
. . . .Organon will pay $34 million to settle allegations that it underpaid rebates to state Medicaid programs, offered improper financial incentives to nursing home pharmacy companies, promoted its antidepressants for unapproved uses, and misrepresented its drug prices to New York’s Medicaid program.. . .
Have a great weekend away (if you can go) -- I know I will too!
1 comment:
Oh my. I did see that, and mentioned it as scolding note, yesterday.
But you are certainly right -- I'll write a whole post on it over the weekend: Merck buying a whole company, to become "invincible" on the 10 per cent patent royalty demanded, from Gilead on Sovaldi revenue!
Great catch!
Do stop back -- Namaste!
Post a Comment